. Author manuscript; available in PMC: 2019 Oct 11.

Published in final edited form as: Kidney Int. 2016 Feb 26;89(5):1111–1118. doi: 10.1016/j.kint.2015.12.041

Table 2 |.

Comparison of the characteristics at the time of CVE between early and late CVEs in GDCN and TGNR cohorts

Characteristics at the time of CVEs	GDCN (N = 31)
Characteristics at the time of CVEs	Early CVE (N = 21)	Late CVE (N = 10)	P value
Age (years)	64 ± 11	62 ± 11	0.71
eGFR (ml/min/1.73 m²)	47 ± 24	57 ± 27	0.40
Proteinuria (g/d)	7.6 ± 4.1	2.2 ± 1.5	<0.001
Serum albumin (g/dl)	2.5 ± 0.7	3.6 ± 0.4	<0.001
Characteristics at the time of CVEs	TGNR (N = 21)
Characteristics at the time of CVEs	Early CVE (N = 11)	Late CVE (N = 10)	P value
Age (years)	62 ± 11	59 ± 9	0.61
eGFR (ml/min/1.73 m²)	50 ± 27	51 ± 19	0.81
Proteinuria (g/d)	7.5 ± 2.8	2.9 ± 1.8	<0.001
Serum albumin (g/dl)	2.7 ± 0.9	3.5 ± 0.6	0.02

Early CVE defined as occurrence ≤2 years from time of biopsy and late CVE defined as an occurrence >2 years from time of biopsy.

CVE, cardiovascular event; eGFR, estimated glomerular filtration rate; GDCN, Glomerular Disease Collaborative Network; MN, membranous nephropathy; PY, person-years; TGNR, Toronto Glomerulonephritis Registry.